VYND
Vynleads, Inc.0.3161
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
5.79MP/E (TTM)
-Basic EPS (TTM)
-0.01Dividend Yield
0%Recent Filings
10-K
FY2025 results
Vynleads posted FY2025 ended December 31, 2025 net loss of $255,066, narrowing 2.3% from $261,192 in 2024 amid zero revenues both years, while operating expenses edged up 3.4% to $247,318 on back-office ramp-up. Costs decelerated sharply, with cost of revenue plunging 56% to $6,499; cash burned $108,860 from operations, down from $112,390 prior year. Notes payable doubled to $165,322, all current, fueling a $352K working capital deficit. No buybacks or dividends. Transition to app subscriptions stalled. Weak retention threatens momentum.
10-Q
Q3 FY2025 results
Vynleads posted zero revenue for Q3 ended September 30, 2025, with operating loss of $56,612 (up 10% y/y from $51,405) on higher selling expenses from third-party software development, while net loss of $58,069 edged prior year's $58,658 thanks to lower interest. Nine-month net loss narrowed slightly to $196,120 from $197,545, matching 18.3M diluted shares at $(0.01) EPS. Cash dwindled to $36K from $69K, drained by $82K operating outflows, offset by $50K new notes; total debt hit $130K, all current and three in default. No revenue yet. Controls falter on segregation lapses.
10-Q
Q2 FY2025 results
Vynleads posted zero revenue for Q2 FY2025 ended June 30, 2025, matching last year, while narrowing its operating loss to $56,133 from $55,957 (y/y flat) and net loss to $57,081 from $58,271. Six-month net loss held steady at $138,051 versus $138,887 prior year, driven by steady in-kind CEO services of $65,000 offsetting slight SG&A creep from third-party software work. Cash dwindled to $346 amid $68,142 operating outflows, with all $80,296 notes payable in default. Stockholders' deficit widened to $300,416. Cash burns fast.
10-Q
Q1 FY2025 results
Vynleads posted zero revenue for Q1 FY2025 ended March 31, 2025, matching Q1 2024, with gross loss widening to $4,718 from $4,235 y/y on higher cost of revenue. Operating loss climbed to $80,031 from $73,990 y/y, driven by SG&A up 8% to $75,313 from third-party software development; net loss edged to $80,970 from $80,616, as interest expense fell to $939 from $6,626. Cash drained $42,333 q/q to $26,655, with operating cash use at $41,833; all $80,282 notes payable in default. Stockholders' deficit deepened to $275,835. No non-GAAP metrics disclosed in the 10-Q. Cash burn persists.
10-K
FY2024 results
Vynleads posted zero revenue for FY2024 ended December 31, 2024, matching 2023's blank slate, while narrowing its net loss to $261,192 from $263,437—a slim $2,245 improvement. Operating expenses ticked up 1.5% to $239,239, driven by back office ramp-up, yet cost of revenue plunged 58% to $14,893 as activity idled. Q4 saw aggressive debt cleanup, converting $572K in notes to equity, slashing liabilities from $805K to $315K and boosting cash to $69K. Financing delivered $167K, trimming operating cash burn to $112K. Debt overhang lingers. COVID-19 lingers as a demand killer.
IPO
Website
Employees
Sector
Industry
BRGX
BioRegenx, Inc
0.02+0.00
DRIO
DarioHealth Corp.
12.05+0.05
FOXO
FOXO Technologies Inc.
0.00+0.00
HYDTF
Hydreight Technologies Inc
3.10-0.06
LFMD
LifeMD, Inc.
3.42+0.15
LVCE
LIVECARE INC
0.01+0.00
OMDA
Omada Health, Inc.
14.61+0.02
SYIN
Synbio International Inc.
0.00-0.00
TDOC
Teladoc Health, Inc.
7.41+0.07
VSEE
VSee Health, Inc.
0.45-0.02